Back to
Tudor Investment Corp.
TVTX
Showing 8 of 22 quarters
Position history for
Tudor Investment Corp.'s holdings in Travere Therapeutics, Inc.
No. Tudor Investment exited its TVTX (Travere Therapeutics) position in Q3 2026. Its Q2 2026 13F listed 5,955 shares worth $338,304. Tudor Investment first reported TVTX in Q2 2021 and held it in 19 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$752,770
Total Shares Change
-43,213
Quarter-by-Quarter History